Additional file 3: of The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines

Linn Reinholdt (Creator)
Maria Bach Laursen (Creator)
Alexander Schmitz (Creator)
Julie Støve Bødker (Aalborg University) (Creator)
Lasse Hjort Kyneb Jakobsen (Creator)
Martin Bøgsted (Creator)
Hans Erik Johnsen (Aalborg University) (Creator)
Karen Dybkær (Contributor)

Dataset

Description

Data used to generate Figure 2. (XLSX 18 kb)

Date made available	2016
Publisher	Figshare

DOI
10.6084/m9.figshare.c.3618047_d4

Access Dataset

CC BY + CC0

1 Journal article

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines
Reinholdt, L., Laursen, M. B., Schmitz, A., Bødker, J. S., Jakobsen, L. H., Bøgsted, M., Johnsen, H. E. & Dybkær, K., 2016, In: Biomarker Research. 4, 12 p., 12.
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
30 Citations (Scopus)

Cite this

Reinholdt, L. (Creator), Laursen, M. B. (Creator), Schmitz, A. (Creator), Bødker, J. S. (Creator), Jakobsen, L. H. (Creator), Bøgsted, M. (Creator), Johnsen, H. E. (Creator), Dybkaer, K. (Contributor) (2016). Additional file 3: of The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines. Figshare. 10.6084/m9.figshare.c.3618047_d4

Additional file 3: of The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines

Description

DOI

Access Dataset

Research output

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines

Cite this